Summary of Purpose
The study will be a multicentre, prospective, randomized, open label, blinded endpoint (PROBE) phase 3 trial (2 arm with 1:1 randomization) in ischemic stroke patients within 4.5 hours of stroke onset. Randomised patients will be stratified for site of baseline arterial occlusion into one of three groups: 1. internal carotid artery (ICA) 2. middle cerebral artery (MCA) 3. basilar artery (BA). Patients will be...Read More →
The following dates are available for this trial. Trial information last updated on 29 April 2018.
|27 Apr 2018||4 Apr 2018||1 Feb 2021||1 May 2021||1 Apr 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Bernard Yan, MD
- Michele Sallaberger
email@example.com +61 3 9035 7269